The role of limited life expectancy in personalized treatment decisions: one in six patients aged 80+ years with a basal cell carcinoma die within 2 years of diagnosis in England.

IF 9.6 1区医学 Q1 DERMATOLOGY

British Journal of Dermatology Pub Date : 2025-08-18 DOI:10.1093/bjd/ljaf135

Opeoluwa Fariyike, Nicholas A Johnson, Birgitta van Bodegraven, Kate Quirke, Zoe C Venables, James Powell

引用次数: 0

查看原文本刊更多论文

有限的预期寿命在个性化治疗决策中的作用：在英国，每6名80岁以上的基底细胞癌患者中就有1人在诊断后2年内死亡。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

British Journal of Dermatology 医学-皮肤病学

CiteScore

16.30

自引率

3.90%

发文量

1062

审稿时长

2-4 weeks

期刊介绍： The British Journal of Dermatology (BJD) is committed to publishing the highest quality dermatological research. Through its publications, the journal seeks to advance the understanding, management, and treatment of skin diseases, ultimately aiming to improve patient outcomes.